DMAC

DiaMedica Therapeutics Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website diamedica.com
Employees(FY) 16
ISIN CA25253X2077

Performance

-5.6%

+10.49%

+35.32%

+63.43%

+8.66%

YTD

+109.22%

Profile

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. The company develops treatments for neurological disorders and cardio-renal disease. Its lead candidate is DM199, a pharmaceutically active recombinant form of the kallikrein-1 protein for the treatment of acute ischemic stroke and other vascular diseases. It is also developing DM300 that is in preclinical stage of development for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Advanced Technical Analysis

Technical Analysis of DMAC 2025-02-03

The stock exhibits a strong bullish sentiment with a Moving Average Score of 83 and a Technical Score of 79, indicating robust upward momentum. However, the Oscillators Score of 53 suggests a neutral stance, implying that while the overall trend is positive, there may be some short-term fluctuations to watch for.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of DMAC

Stock Rank

Recent News & Updates

2023-12-04 01:56
Billionaire Lee Coopermans 10 Stock Picks with Huge Upside Potential(Yahoo Finance)
2023-11-14 23:15
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript(Insidermonkey)
2023-11-14 09:54
Q3 2023 DiaMedica Therapeutics Inc Earnings Call(Yahoo Finance)
2023-11-14 01:53
DiaMedica Therapeutics Inc. (DMAC) Reports Third Quarter 2023 Financial Results(Yahoo Finance)
2023-11-13 03:28
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results(Businesswire)
2023-11-08 19:25
DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023(Businesswire)
2023-11-05 19:23
DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023(Businesswire)
2023-09-11 20:13
DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer(Yahoo Finance)
2023-09-05 20:35
DiaMedica Therapeutics to Participate at Lake Streets 7th Annual Best Ideas Growth Conference(Yahoo Finance)
2023-08-30 21:40
Is DiaMedica Therapeutics (DMAC) Stock Outpacing Its Medical Peers This Year?(Yahoo Finance)
2023-08-15 09:19
Q2 2023 DiaMedica Therapeutics Inc Earnings Call(Yahoo Finance)
2023-08-14 04:13
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results(Yahoo Finance)
2023-08-07 20:32
DiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023(Yahoo Finance)
2023-07-17 20:30
DiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conference(Yahoo Finance)
2023-06-25 20:30
DiaMedica Therapeutics Announces Closing of $37.5 Million Private Placement(Yahoo Finance)
2023-06-20 20:39
DiaMedica Therapeutics Announces $37.5 Million Private Placement(Yahoo Finance)
2023-06-20 20:15
DiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke(Yahoo Finance)
2023-05-29 20:29
DiaMedica Therapeutics Announces Appointment of Dr. Richard Kuntz to the Board of Directors(Yahoo Finance)
2023-05-17 01:50
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2023 Earnings Call Transcript(Yahoo Finance)
2023-05-16 09:38
Q1 2023 DiaMedica Therapeutics Inc Earnings Call(Yahoo Finance)
2023-05-15 04:28
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results(Yahoo Finance)
2023-05-12 21:23
Bullish DiaMedica Therapeutics Insiders Loaded Up On US$5.2m Of Stock \(Yahoo Finance)
2023-05-07 20:50
DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023(Yahoo Finance)
2023-04-10 20:41
DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer(Yahoo Finance)
2023-03-30 16:29
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2022 Earnings Call Transcript(Yahoo Finance)
2023-03-28 04:30
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results(Yahoo Finance)
2023-03-20 04:17
DiaMedica Therapeutics to Report Fourth Quarter 2023 Financial Results and Provide a Business Update March 29, 2023(Yahoo Finance)
2023-03-12 20:00
DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference(Yahoo Finance)
2023-03-05 19:30
DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors(Yahoo Finance)
2022-12-30 19:02
We Think DiaMedica Therapeutics (NASDAQ:DMAC) Can Afford To Drive Business Growth(Yahoo Finance)

Page 2 of 5

previous next

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.